Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4850 Target Snapshot

Receptor-type tyrosine-protein phosphatase epsilon · SINGLE PROTEIN · Homo sapiens

62Compounds
23Assays
0Approved Drugs
61.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P23469. Use UniProt P23469 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P23469 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Receptor-type tyrosine-protein phosphatase epsilon as ChEMBL target CHEMBL4850, mapped to UniProt P23469. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Receptor-type tyrosine-protein phosphatase epsilon
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4850
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P23469
Receptor-type tyrosine-protein phosphatase epsilon
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Receptor-type tyrosine-protein phosphatase epsilon is the right protein anchor across sources, using UniProt P23469 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelReceptor-type tyrosine-protein phosphatase epsilon
UniProt AccessionP23469
Component TypeProtein
Sequence Length700 aa

Receptor-type tyrosine-protein phosphatase epsilon

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Receptor-type tyrosine-protein phosphatase epsilon, mapped to UniProt P23469. Sequence length is 700 aa.

Mapped IDP23469
Review nameReceptor-type tyrosine-protein phosphatase epsilon
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5050.0
KI11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4174865 5.73 IC50 1860.0 Preclinical
CHEMBL4160163 5.7 IC50 2010.0 Preclinical
CHEMBL4170383 5.61 IC50 2470.0 Preclinical
CHEMBL4168082 5.43 IC50 3700.0 Preclinical
CHEMBL4159748 5.38 IC50 4170.0 Preclinical
CHEMBL138806 4.7 Ki 20000.0 Preclinical
CHEMBL336908 4.48 Ki 33000.0 Preclinical
CHEMBL341806 4.48 Ki 33000.0 Preclinical
CHEMBL138152 4.35 Ki 45000.0 Preclinical
CHEMBL573989 4.35 Ki 45000.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
3
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

23
Total Assays
15
Tested Compounds
2
Assay Types
Binding — 22 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 18 10 4.4
assay format 3 5 5.6
cell-based format 1 0
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine